MLV & Co. Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: MLV & Co.
Rating: 2.6
Author: MarketBeat

View the latest stock recommendations issued by analysts at MLV & Co.. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from MLV & Co.'s equity research team. MarketBeat is not affiliated with or endorsed by MLV & Co..

Updated 12/3/2015

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 0 Last 12 Months
Buy Ratings: 0 Last 12 Months
Sell Ratings: 0 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
DOC Healthpeak Properties	$20.64 -0.2%	12/3/2015		Reiterated Rating	$16.00 ➝ $19.00	Buy	View details for MLV & Co. rating of Healthpeak Properties (NYSE:DOC) on 12/3/2015
GALT Galectin Therapeutics	$2.67	8/12/2015	Vernon Bernardino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$16.00	Buy	View details for MLV & Co. rating of Galectin Therapeutics (NASDAQ:GALT) on 8/12/2015
KPTI Karyopharm Therapeutics	$9.50	8/12/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$810.00 ➝ $630.00	Buy	View details for MLV & Co. rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 8/12/2015
MCF Contango Oil & Gas	$3.22 +3.5%	8/12/2015	Chad Mabry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$20.00 ➝ $15.00	Buy	View details for MLV & Co. rating of Contango Oil & Gas (NYSEAMERICAN:MCF) on 8/12/2015
OMER Omeros	$8.73	8/11/2015	Ram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$38.00	Buy	View details for MLV & Co. rating of Omeros (NASDAQ:OMER) on 8/11/2015
BCRX BioCryst Pharmaceuticals	$8.70	8/10/2015		Reiterated Rating	$15.00	Buy	View details for MLV & Co. rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 8/10/2015
GERN Geron	$1.15	8/10/2015	Thomas Yip Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$6.00	Buy	View details for MLV & Co. rating of Geron (NASDAQ:GERN) on 8/10/2015
MDGL Madrigal Pharmaceuticals	$480.77	8/10/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$6.50	Buy	View details for MLV & Co. rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 8/10/2015
HTGC Hercules Capital	$15.51 +0.0%	8/7/2015		Upgrade	$13.00	Hold ➝ Buy	View details for MLV & Co. rating of Hercules Capital (NYSE:HTGC) on 8/7/2015
SLS SELLAS Life Sciences Group	$7.83	8/7/2015	Vernon Bernardino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$250.00	Buy	View details for MLV & Co. rating of SELLAS Life Sciences Group (NASDAQ:SLS) on 8/7/2015
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
PNNT PennantPark Investment	$3.86 +0.1%	8/6/2015	Christopher Nolan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$11.00 ➝ $10.00	Buy	View details for MLV & Co. rating of PennantPark Investment (NASDAQ:PNNT) on 8/6/2015
CGEN Compugen	$2.04	8/5/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00	Buy	View details for MLV & Co. rating of Compugen (NASDAQ:CGEN) on 8/5/2015
RLJ RLJ Lodging Trust	$11.02 0.0%	8/5/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$35.00	Buy	View details for MLV & Co. rating of RLJ Lodging Trust (NYSE:RLJ) on 8/5/2015
XNCR Xencor	$12.33	8/5/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$22.00 ➝ $29.00	Buy	View details for MLV & Co. rating of Xencor (NASDAQ:XNCR) on 8/5/2015
GEO Geo Group	$28.40 -0.1%	8/4/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$28.67	Buy	View details for MLV & Co. rating of Geo Group (NYSE:GEO) on 8/4/2015
INN Summit Hotel Properties	$6.21 +0.1%	8/4/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$16.00	Buy	View details for MLV & Co. rating of Summit Hotel Properties (NYSE:INN) on 8/4/2015
AIV Apartment Investment and Management	$2.88 -0.2%	8/3/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$43.00	Hold	View details for MLV & Co. rating of Apartment Investment and Management (NYSE:AIV) on 8/3/2015
ESS Essex Property Trust	$283.40 -0.1%	8/3/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$237.00	Hold	View details for MLV & Co. rating of Essex Property Trust (NYSE:ESS) on 8/3/2015
MAR Marriott International	$402.54	8/3/2015		Reiterated Rating	$78.00	Hold	View details for MLV & Co. rating of Marriott International (NASDAQ:MAR) on 8/3/2015
AI C3.ai	$10.91 +0.0%	7/31/2015	Rich Eckert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$24.25 ➝ $21.25	Hold	View details for MLV & Co. rating of C3.ai (NYSE:AI) on 7/31/2015
WES Western Midstream Partners	$44.42 -0.3%	7/31/2015	Suzanne Hannigan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$71.00 ➝ $75.00	Buy	View details for MLV & Co. rating of Western Midstream Partners (NYSE:WES) on 7/31/2015
HST Host Hotels & Resorts	$24.89	7/30/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$22.00	Hold	View details for MLV & Co. rating of Host Hotels & Resorts (NASDAQ:HST) on 7/30/2015
AGEN Agenus	$3.30	7/27/2015		Reiterated Rating	$180.00 ➝ $220.00	Buy	View details for MLV & Co. rating of Agenus (NASDAQ:AGEN) on 7/27/2015
CYTK Cytokinetics	$70.15	7/24/2015	Vernon Bernardino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$9.00 ➝ $14.00	Buy	View details for MLV & Co. rating of Cytokinetics (NASDAQ:CYTK) on 7/24/2015
GEL Genesis Energy	$15.03 -0.7%	7/21/2015	Daniel Schenk Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$60.00 ➝ $57.00	Buy	View details for MLV & Co. rating of Genesis Energy (NYSE:GEL) on 7/21/2015
ABEO Abeona Therapeutics	$5.53	7/20/2015		Initiated Coverage	$375.00	Buy	View details for MLV & Co. rating of Abeona Therapeutics (NASDAQ:ABEO) on 7/20/2015
DX Dynex Capital	$12.92 -0.1%	7/20/2015	Rich Eckert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$27.15 ➝ $25.50	Hold ➝ Buy	View details for MLV & Co. rating of Dynex Capital (NYSE:DX) on 7/20/2015
ORMP Oramed Pharmaceuticals	$3.87	7/8/2015	Ram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for MLV & Co. rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 7/8/2015
EYPT Eyepoint Pharmaceuticals	$13.03	7/7/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$650.00	Buy	View details for MLV & Co. rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 7/7/2015
CERS Cerus	$2.56	6/30/2015	Thomas Yip Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Buy	View details for MLV & Co. rating of Cerus (NASDAQ:CERS) on 6/30/2015
ORMP Oramed Pharmaceuticals	$3.87	6/30/2015	Ram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$30.00	Buy	View details for MLV & Co. rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 6/30/2015
ADXS Ayala Pharmaceuticals	$0.60	6/26/2015	Ram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage		Buy	View details for MLV & Co. rating of Ayala Pharmaceuticals (NASDAQ:ADXS) on 6/26/2015
CGEN Compugen	$2.04	6/25/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00	Buy	View details for MLV & Co. rating of Compugen (NASDAQ:CGEN) on 6/25/2015
CPRX Catalyst Pharmaceuticals	$31.36	6/24/2015		Initiated Coverage	$14.00	Buy	View details for MLV & Co. rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 6/24/2015
ADXS Ayala Pharmaceuticals	$0.60	6/20/2015	Ram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$34.00	Buy	View details for MLV & Co. rating of Ayala Pharmaceuticals (NASDAQ:ADXS) on 6/20/2015
TGTX TG Therapeutics	$49.52	6/20/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$22.00	Buy	View details for MLV & Co. rating of TG Therapeutics (NASDAQ:TGTX) on 6/20/2015
OMER Omeros	$8.73	6/18/2015	Ram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$38.00	Buy	View details for MLV & Co. rating of Omeros (NASDAQ:OMER) on 6/18/2015
ORMP Oramed Pharmaceuticals	$3.87	6/18/2015	Ram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$30.00	Buy	View details for MLV & Co. rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 6/18/2015
EFC Ellington Financial	$13.69 +0.0%	6/16/2015	Rich Eckert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$21.75 ➝ $21.00	Hold ➝ Buy	View details for MLV & Co. rating of Ellington Financial (NYSE:EFC) on 6/16/2015
EYPT Eyepoint Pharmaceuticals	$13.03	6/12/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$650.00	Buy	View details for MLV & Co. rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 6/12/2015
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad) Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. See which companies control the supply chain behind this emerging tech
CGEN Compugen	$2.04	6/11/2015	George Zavoico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$14.00	Buy	View details for MLV & Co. rating of Compugen (NASDAQ:CGEN) on 6/11/2015
TGTX TG Therapeutics	$49.52	6/2/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$22.00	Buy	View details for MLV & Co. rating of TG Therapeutics (NASDAQ:TGTX) on 6/2/2015
HALO Halozyme Therapeutics	$69.50	6/1/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	View details for MLV & Co. rating of Halozyme Therapeutics (NASDAQ:HALO) on 6/1/2015
ADXS Ayala Pharmaceuticals	$0.60	5/14/2015		Initiated Coverage	$34.00	Buy	View details for MLV & Co. rating of Ayala Pharmaceuticals (NASDAQ:ADXS) on 5/14/2015
CTSO Cytosorbents	$0.40	5/12/2015		Lower Price Target	$28.00 ➝ $21.00	Buy	View details for MLV & Co. rating of Cytosorbents (NASDAQ:CTSO) on 5/12/2015
MCF Contango Oil & Gas	$3.22 +3.5%	5/12/2015	Chad Mabry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$29.00 ➝ $25.00	Buy	View details for MLV & Co. rating of Contango Oil & Gas (NYSEAMERICAN:MCF) on 5/12/2015
MNKD MannKind	$3.66	5/11/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$7.00 ➝ $4.00	Hold	View details for MLV & Co. rating of MannKind (NASDAQ:MNKD) on 5/11/2015
PSEC Prospect Capital	$2.31	5/10/2015	Christopher Nolan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.50 ➝ $9.00	Buy	View details for MLV & Co. rating of Prospect Capital (NASDAQ:PSEC) on 5/10/2015
GERN Geron	$1.15	5/9/2015	Thomas Yip Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$6.00	Buy	View details for MLV & Co. rating of Geron (NASDAQ:GERN) on 5/9/2015
AGIO Agios Pharmaceuticals	$29.46	5/8/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$130.00	Buy	View details for MLV & Co. rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 5/8/2015
AUPH Aurinia Pharmaceuticals	$15.82	5/8/2015		Initiated Coverage	$9.00	Buy	View details for MLV & Co. rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 5/8/2015
GLP Global Partners	$47.44 +0.7%	5/8/2015	Daniel Schenk Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Hold	View details for MLV & Co. rating of Global Partners (NYSE:GLP) on 5/8/2015
HTGC Hercules Capital	$15.51 +0.0%	5/8/2015		Reiterated Rating		Hold	View details for MLV & Co. rating of Hercules Capital (NYSE:HTGC) on 5/8/2015
PNNT PennantPark Investment	$3.86 +0.1%	5/8/2015	Christopher Nolan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$11.00	Buy	View details for MLV & Co. rating of PennantPark Investment (NASDAQ:PNNT) on 5/8/2015
TCPC Blackrock Tcp Capital	$3.79	5/8/2015	Christopher Nolan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$19.00	Buy	View details for MLV & Co. rating of Blackrock Tcp Capital (NASDAQ:TCPC) on 5/8/2015
REI Ring Energy	$1.29	5/7/2015	Chad Mabry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$15.00	Buy	View details for MLV & Co. rating of Ring Energy (NYSEAMERICAN:REI) on 5/7/2015
ARR ARMOUR Residential REIT	$17.11 +0.0%	5/6/2015	Rich Eckert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$17.50 ➝ $17.75	Hold	View details for MLV & Co. rating of ARMOUR Residential REIT (NYSE:ARR) on 5/6/2015
CERS Cerus	$2.56	5/6/2015	Thomas Yip Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$10.00	Buy	View details for MLV & Co. rating of Cerus (NASDAQ:CERS) on 5/6/2015
TGTX TG Therapeutics	$49.52	5/6/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$22.00	Buy	View details for MLV & Co. rating of TG Therapeutics (NASDAQ:TGTX) on 5/6/2015
XNCR Xencor	$12.33	5/5/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$22.00	Buy	View details for MLV & Co. rating of Xencor (NASDAQ:XNCR) on 5/5/2015
CYTK Cytokinetics	$70.15	5/1/2015	George Zavoico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$9.00	Buy	View details for MLV & Co. rating of Cytokinetics (NASDAQ:CYTK) on 5/1/2015
MMLP Martin Midstream Partners	$2.68 -0.4%	5/1/2015		Reiterated Rating	$39.00	Buy	View details for MLV & Co. rating of Martin Midstream Partners (NASDAQ:MMLP) on 5/1/2015
OCSL Oaktree Specialty Lending	$12.13	5/1/2015	Christopher Nolan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Hold	View details for MLV & Co. rating of Oaktree Specialty Lending (NASDAQ:OCSL) on 5/1/2015
AI C3.ai	$10.91 +0.0%	4/30/2015	Rich Eckert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Hold	View details for MLV & Co. rating of C3.ai (NYSE:AI) on 4/30/2015
DX Dynex Capital	$12.92 -0.1%	4/30/2015	Rich Eckert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$27.15	Hold	View details for MLV & Co. rating of Dynex Capital (NYSE:DX) on 4/30/2015
GEL Genesis Energy	$15.03 -0.7%	4/30/2015	Daniel Schenk Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$60.00	Buy	View details for MLV & Co. rating of Genesis Energy (NYSE:GEL) on 4/30/2015
GEO Geo Group	$28.40 -0.1%	4/30/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$33.33	Buy	View details for MLV & Co. rating of Geo Group (NYSE:GEO) on 4/30/2015
MAR Marriott International	$402.54	4/30/2015		Reiterated Rating	$85.00	Hold	View details for MLV & Co. rating of Marriott International (NASDAQ:MAR) on 4/30/2015
AAT American Assets Trust	$24.40 0.0%	4/29/2015	Paul Morgan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$42.00	Buy	View details for MLV & Co. rating of American Assets Trust (NYSE:AAT) on 4/29/2015
MAIN Main Street Capital	$52.05 +0.1%	4/29/2015		Set Price Target	$35.00	Buy	View details for MLV & Co. rating of Main Street Capital (NYSE:MAIN) on 4/29/2015
AI C3.ai	$10.91 +0.0%	4/28/2015	Rich Eckert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$26.00	Buy	View details for MLV & Co. rating of C3.ai (NYSE:AI) on 4/28/2015
PNNT PennantPark Investment	$3.86 +0.1%	4/28/2015	Christopher Nolan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$11.00	Buy	View details for MLV & Co. rating of PennantPark Investment (NASDAQ:PNNT) on 4/28/2015
DRH DiamondRock Hospitality	$11.92	4/27/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$17.00	Buy	View details for MLV & Co. rating of DiamondRock Hospitality (NYSE:DRH) on 4/27/2015
SPG Simon Property Group	$218.79 -0.1%	4/26/2015		Reiterated Rating	$207.00	Hold	View details for MLV & Co. rating of Simon Property Group (NYSE:SPG) on 4/26/2015
PLD Prologis	$148.49 -0.2%	4/21/2015	Jonathan Petersen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$47.00	Hold	View details for MLV & Co. rating of Prologis (NYSE:PLD) on 4/21/2015
FRT Federal Realty Investment Trust	$125.73 -0.1%	4/20/2015	Paul Morgan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$134.00 ➝ $146.00	Buy	View details for MLV & Co. rating of Federal Realty Investment Trust (NYSE:FRT) on 4/20/2015
LTC LTC Properties	$36.84 +0.0%	4/20/2015	Paul Morgan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$42.00 ➝ $47.00	Buy	View details for MLV & Co. rating of LTC Properties (NYSE:LTC) on 4/20/2015
REI Ring Energy	$1.29	4/15/2015		Initiated Coverage	$15.00	Buy	View details for MLV & Co. rating of Ring Energy (NYSEAMERICAN:REI) on 4/15/2015
OMER Omeros	$8.73	4/14/2015	Ram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$38.00	Buy	View details for MLV & Co. rating of Omeros (NASDAQ:OMER) on 4/14/2015
ORMP Oramed Pharmaceuticals	$3.87	4/13/2015		Initiated Coverage	$27.00 ➝ $30.00	Buy	View details for MLV & Co. rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 4/13/2015
HALO Halozyme Therapeutics	$69.50	4/8/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for MLV & Co. rating of Halozyme Therapeutics (NASDAQ:HALO) on 4/8/2015
ARR ARMOUR Residential REIT	$17.11 +0.0%	4/7/2015	Rich Eckert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$17.50	Hold	View details for MLV & Co. rating of ARMOUR Residential REIT (NYSE:ARR) on 4/7/2015
GEO Geo Group	$28.40 -0.1%	4/2/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$33.33	Buy	View details for MLV & Co. rating of Geo Group (NYSE:GEO) on 4/2/2015
CTSO Cytosorbents	$0.40	4/1/2015		Boost Price Target	$28.00 ➝ $30.00	Buy	View details for MLV & Co. rating of Cytosorbents (NASDAQ:CTSO) on 4/1/2015
FBIO Fortress Biotech	$2.77	3/31/2015		Upgrade	$30.00 ➝ $105.00	Hold ➝ Buy	View details for MLV & Co. rating of Fortress Biotech (NASDAQ:FBIO) on 3/31/2015
RARE Ultragenyx Pharmaceutical	$24.35	3/30/2015		Initiated Coverage	$79.00	Buy	View details for MLV & Co. rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 3/30/2015
INN Summit Hotel Properties	$6.21 +0.1%	3/26/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$16.00	Buy	View details for MLV & Co. rating of Summit Hotel Properties (NYSE:INN) on 3/26/2015
SBLK Star Bulk Carriers	$27.15	3/23/2015		Lower Price Target	$9.00 ➝ $6.00	Buy	View details for MLV & Co. rating of Star Bulk Carriers (NASDAQ:SBLK) on 3/23/2015
SLS SELLAS Life Sciences Group	$7.83	3/23/2015	Vernon Bernardino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$250.00	Buy	View details for MLV & Co. rating of SELLAS Life Sciences Group (NASDAQ:SLS) on 3/23/2015
GEO Geo Group	$28.40 -0.1%	3/19/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$33.33	Buy	View details for MLV & Co. rating of Geo Group (NYSE:GEO) on 3/19/2015
The REAL Reason Trump is Invading Iran (Ad) For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is.
GLP Global Partners	$47.44 +0.7%	3/18/2015	Daniel Schenk Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Hold	View details for MLV & Co. rating of Global Partners (NYSE:GLP) on 3/18/2015
NVGS Navigator	$23.01 +0.1%	3/18/2015		Lower Price Target	$28.00 ➝ $20.00	Hold	View details for MLV & Co. rating of Navigator (NYSE:NVGS) on 3/18/2015
KPTI Karyopharm Therapeutics	$9.50	3/16/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$810.00	Buy	View details for MLV & Co. rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 3/16/2015
TGTX TG Therapeutics	$49.52	3/15/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$22.00	Buy	View details for MLV & Co. rating of TG Therapeutics (NASDAQ:TGTX) on 3/15/2015
MDGL Madrigal Pharmaceuticals	$480.77	3/13/2015	Arlinda Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$6.50	Buy	View details for MLV & Co. rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/13/2015
OMER Omeros	$8.73	3/13/2015	Ram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$38.00	Buy	View details for MLV & Co. rating of Omeros (NASDAQ:OMER) on 3/13/2015
GALT Galectin Therapeutics	$2.67	3/12/2015	Vernon Bernardino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$16.00	Buy	View details for MLV & Co. rating of Galectin Therapeutics (NASDAQ:GALT) on 3/12/2015
TCPC Blackrock Tcp Capital	$3.79	3/11/2015	Christopher Nolan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$19.00	Buy	View details for MLV & Co. rating of Blackrock Tcp Capital (NASDAQ:TCPC) on 3/11/2015
AHT Ashford Hospitality Trust	$2.97 +0.2%	3/9/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$1,400.00	Buy	View details for MLV & Co. rating of Ashford Hospitality Trust (NYSE:AHT) on 3/9/2015
INN Summit Hotel Properties	$6.21 +0.1%	3/9/2015	Ryan Meliker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$16.00	Buy	View details for MLV & Co. rating of Summit Hotel Properties (NYSE:INN) on 3/9/2015

MarketBeat Community Rating for MLV & Co.

MarketBeat's community ratings are surveys of what our community members think about MLV & Co. and other research firms in the last 90 days. Vote "Outperform" if you believe MLV & Co.'s recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe MLV & Co.'s recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 2.6out of 5 (last 90 days)
2.6 of 5 stars
OUTPERFORM VOTES: 18 Believe will outperform the market
UNDERPERFORM VOTES: 16 Believe will underperform the market

Best & Worst Calls

Best Call
0000.0%
NASDAQ:AMSC
Set Price Target • Feb 6, 2015
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
OTCMKTS:MILLQ
Reiterated Rating • Oct 29, 2014
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MLV & Co. Analyst Recommendations & Stock Picks

MarketBeat Community Rating for MLV & Co.

Best & Worst Calls

Similarly Rated Firms